KENNEDY CAPITAL MANAGEMENT LLC
Position in ADPT — Adaptive Biotechnologies Corp
CIK 884589
ST LOUIS, MO
Position in ADPT
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$12,929,525
-$1,690,226 QoQ
Shares Held
931,522
+3.5% QoQ
Ownership
0.582%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 93.72972404301777.ToString("F0")%
Shared 0.ToString("F0")%
None 6.27027595698223.ToString("F0")%
Common Shares in ADPT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026KENNEDY CAPITAL MANAGEMENT LLC holds $58,272,910 across 13 Diagnostics & Research names. ADPT ranks #2 (22.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PSNL |
Personalis, Inc.
|
2,183,572 | $13,909,353 | |
| 2 | ADPT |
Adaptive Biotechnologies Corp
This page
|
931,522 | $12,929,525 | |
| 3 | CRL |
Charles River Laboratories International, Inc.
|
43,634 | $7,526,865 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
14,073 | $6,917,301 | |
| 5 | A |
Agilent Technologies, Inc.
|
41,202 | $4,696,203 | |
| 6 | DHR |
Danaher Corp /De/
|
14,638 | $2,775,364 | |
| 7 | WGS |
GeneDx Holdings Corp.
|
34,562 | $2,219,571 | |
| 8 | VCYT |
Veracyte, Inc.
|
54,320 | $1,749,647 |
All Filings in ADPT
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,929,525 | 931,522 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $14,619,751 | 900,231 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $19,053,744 | 1,273,646 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $15,120,569 | 1,297,903 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $9,425,504 | 1,268,574 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||